|
[1]
|
Minocycline reduces neurobehavioral deficits evoked by chronic unpredictable stress in adult zebrafish
Brain Research,
2024
DOI:10.1016/j.brainres.2024.149209
|
|
|
|
|
[2]
|
Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia
CNS Drugs,
2022
DOI:10.1007/s40263-022-00935-z
|
|
|
|
|
[3]
|
Anti-inflammatory Augmentation Therapy in Obsessive-compulsive Disorder: A Review
Letters in Drug Design & Discovery,
2020
DOI:10.2174/1570180817999200520122910
|
|
|
|
|
[4]
|
Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline
Psychopharmacology,
2017
DOI:10.1007/s00213-016-4463-y
|
|
|
|
|
[5]
|
Minocycline improves recognition memory and attenuates microglial activation in Gunn rat: A possible hyperbilirubinemia-induced animal model of schizophrenia
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
2014
DOI:10.1016/j.pnpbp.2013.12.017
|
|
|
|
|
[6]
|
Biomarkers in psychosis: an approach to early identification and individualized treatment
Biomarkers in Medicine,
2014
DOI:10.2217/bmm.13.134
|
|
|
|
|
[7]
|
Biomarkers in Psychosis: An Approach to Early Identification and Individualized Treatment
Biomarkers in Medicine,
2014
DOI:10.2217/bmm.13.134
|
|
|
|